s 64 Saving and transitional provisions for legacy human biological material
64.—(1) This Act, with the exception of sections 30 (prohibited human biomedical research), 31 (restricted human biomedical research), 32 (commercial trading of human tissue prohibited) and 33 (advertisements relating to commercial trading of human tissue prohibited), does not apply to any legacy human biological material or any information derived from such material. (2) Despite subsection (1), regulations made under section 63 may provide for the requirements and conditions in relation to the use of legacy human biological material for human biomedical research that are different from the provisions of this Act. (3) In this section, “legacy human biological material” means —(a) any human biological material which has been removed from a human body, whether living or dead, at any time before 1 November 2019; (b) any biological material from the body of a dead person which has been stored for the purposes of human biomedical research at any time before 1 November 2019, and which has been rendered non‑identifiable within the meaning of section 27(3) at any time before 1 November 2019.